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1. Introduction 
Chronic rhinosinusitis (CRS) is a common disease with significant morbidity and health care 
cost. Although the medical and surgical treatments for CRS have improved markedly over 
the past few decades, a subset of patients remains quite resistant to all forms of therapy. 
Such patients end up being over-treated and subjected to numerous unsuccessful surgeries 
some of which can result in serious complications. The optimal treatment for these patients 
(an entity referred to as refractory or recalcitrant sinusitis) (RCRS) is complex and 
challenging. 
The true incidenceof RCRS is unknown. It is estimated that at least 10 % of patients with 
CRS continue to be symptomatic after appropriate endoscopic sinus surgery (ESS) with long 
term follow up. This 10% failure rate translates into 30,000 patients yearlyundergoing ESS 
with poor postoperative outcome.Because these numbers are cumulative over years, 
approximately450,000 cases in the United States are currently estimatedto have chronic 
sinusitis that is unresponsive to medical and surgical therapy. Today, these chronic patients 
form a significant portion of most rhinology practices. (Desrosiers, 2004).  
The aims of this chapter are to review the updated possible pathogesis of RCRS and suggest 
possible algorithmic management plan for this condition. 
2. History and physical examinations 
Thoroughand detailed history is fundamental in evaluating patients to find out whether 
optimal treatment has been given, and whether there are any personal or technical 
predisposing factors. 
Current symptomatology should be determined. Detailed questions regarding nasal 
symptoms: facial pressure, nasal obstruction, anterior or posterior rhinorrhea,and alteration 
of sense of smell should be asked. Frequency and duration of symptoms exacerbation as 
well as different modalities of treatments used should be reviewed. 
Routine medical questions should also be included. Specific attention should be paid to 
thesymptoms of respiratory system, such as cough, wheeze, and shortness of breath.History 
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of recurrent infections in the skin, urinary tract or digestive tract may indicate 
immunodeficiency. Additionally, connective tissue disorders, granulomatous diseases and 
vasculatitis related symptoms need be asked. 
Medication should be reviewed and the use of oral immunosuppressive agents determined. 
Allergy questionnaires should cover presence of household pets or excess mold in the 
domestic environment. Work history should be obtained to evaluate occupational causative 
elements to the disease. Both smoking historyand passive exposure to smoke should be 
assessed. 
Previous nasal surgeries reviewed. Type of surgery, recovery, complications and response 
should all be documented. 
Complete ear, nose, and throat examination is followed. Anterior rhinoscopy should assess 
nasal patency, nasal mucosa condition, inferior turbinates, and the presence of nasal 
crusting.  
Direct visualization using 0 and 30 degree rigid endoscopy is crucial in this group of 
patients, to look for any evidenceof active infection or obstruction to sinus ostium. The 
presence of polyps, pus,synechiae,stenosis, middle turbinate lateralization should also be 
evaluated.Pathological looking mucosa can be biopsied under local anesthesia as office 
procedure to rule out systemic diseases or tumors. 
 
 
Fig. 1. Coronal CT scan for patient with RCRS, thickened mucosa with patent sinus ostium 
and Osteitis of the left lateral maxillary wall. 
If surgery is not technically adequate and evidence of obstruction noticed revision surgery is 
offered. 
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Thin cut CT scan with coronal and sagital reconstruction should be ordered. CT scan can 
illustrate detail in lateral wall of sinuses where the endoscopic view cannot reach.Extent of 
sinus involvement, extent of prior surgery, presence of obstruction to sinus drainage, 
unventilated cells, development of new bone deposition or neo-osteogenesis, and evidence 
of previous intraoperative complications can be easily visualized. Figure 1 showed the 
typical CT scan finding in patients with RCRS. 
3. Pathogenesis and treatment 
3.1 Immunodeficiency & RCRS 
Although the exact role of bacteria and fungus in the etiology of sinusitis is still 
controversial, we have reasonable evidences to believe they play significant role in this wide 
spectrum disease. Bacteria and fungus have been detected in endoscopic guided culture,  
type of organisms identified in acute sinusitis differs from those reported in chronic and in 
RCRS. In general, patients with sinusitis report improvement in their symptoms while they 
are on Antibiotics. Additionally, the prevalence &severity of sinusitis in 
immuncompromised patients correlate with their immunological status. In fact, 
Antimicrobial therapy is still the mostcommon form of therapy prescribed by physiciansfor 
the treatment of CRS. 
Various forms of immunodeficiencies predispose to rhinosinusitis, however in RCRS   the 
most important are selective IgA deficiency and systemic subtle humoral 
immunodeficiencies. These patients are usually diagnosed after being treated with multiple 
sinus surgeries. Other forms of immunodeficiency, for example, common variable 
immunodeficiency lymphopenia or neutropenia are more important in the pathogenesis of 
recurrent acute forms of rhinosinusitis and acute invasive fungal sinusitis. 
Immune dysfunction as a risk factor for RCRS has gained attention in recent years.Chee et al 
studied the incidence of primary immune deficiency in patients with refractory 
sinusitis.Among a group of 79 patients with refractory sinusitis 17.9% were noted to have 
low IgG and 16.7% were noted to have low IgA. Common variable immunodeficiency was 
found in 9.9% and selective IgA deficiency was diagnosed in 6.2%. Although these numbers 
are interesting, the authors included some patients who didn’t fit with the current definition 
of RCRS, they defined refractory sinusitis as at least one previous sinussurgery and/or three 
episodes of objectively documented rhinosinusitis in the previous year ( Cheel et al., 2001). 
Vanleberghe et al. reported on a series of cases with RCRS whohad undergone 
immunologic evaluation. Out of 307(261 adults and 46 children) patients tested, 22% had 
evidence of humoral immunodeficiency.The majority of these were subtle IgG subclass 
deficits, low level of major immunoglobulins was reported in 7% for IgA and 3.3%.for 
IgG. Low level of IgM or Common variable immunodeficiency weren’t detected 
(Vanlerberghe et al., 2006).  
In a recent paper Al-Qudah et al studied the contribution of primary immunodeficiency in 
67 patients with RCRS at a large tertiary care medical center. In addition to major 
immunoglobulin and IgG subclasses blood level, Functional antibody response was 
assessed by examining the antibody response to the unconjugated pneumococcal 
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polysaccharide vaccine. Low IgG was detected in 9%, low IgA in 3%, low IgM in 12% of 
patients, and IgG subclasses in 19%.  Common variable immunodeficiency was diagnosed in 
one case. 67% of patients failed to produce more than a fourfold increase in 
postimmunization antibody titer for 7 of 14 serotypes being tested and were considered to 
have functional antibody deficiency. Interestingly there was no statistically significant 
difference in the incidence of low level of immunoglobulins between patients with normal 
antibody response and poor response group. They recommended measurement of 
serumimmunoglobulin levels in all patients with RCRS; if these are normal, then functional 
antibody responses should be evaluated (Alqudah et al., 2010).  
Functional antibody responses or selective antibody deficiency syndrome is a condition with 
normal or near normal serum immunoglobulin concentrations but an inadequate 
production of specific antibodies response to polysaccharide organisms, which are T-
independent type 2 antigens, like Streptococcus pneumonia. Patient with this condition 
have recurrent respiratory infections such as: sinusitis, bronchitis, and pneumonia.The 
diagnosis can be reached by taking paired blood sample before and 6-weks after 
immunization with pneumococcal vaccine.The consensus recommendation is that a normal 
response in adultsis a fourfold increase in antibody titers to 70% of the14 
serotypesunconjugated pneumococcal polysaccharide and a normal response in children is a 
fourfold increase in antibody titers to 50% of the serotypes tested (Bonilla et al.,2005). 
T cell immunodeficiency patients are unlikely to present with Refractory sinusitis symptoms 
without other apparent clinical presentation. Primary T cell disorders are rare and usually 
diagnosed during childhood. Secondary T cell deficiency presents with unusual or severe 
viral, fungal or protozoal infection. 
Food allergy is another possible cause of persistent nasal symptoms after proper medical 
and surgical therapy especially in patient with nasal polyp. Most common ‘‘masked’’ food 
allergens in adults are those foods commonly eaten and include: wheat, dairy, soy, corn, 
and, eggs (Ferguson et al., 2009). 
The condition is usually difficult to recognize by the patients as symptoms may show up 
hours or even a day after food absorption and the fact that common allergic foods are so 
prevalent in our diet that many patients eat them nearly every day. An elimination food 
challenging test is a convenient and inexpensive procedure that can performed by the 
patient at home. The targeted food is eliminated from the diet for 5 to 7 days and then 
reintroduced into the diet during this hyperresponsive period of 5 to 10 days following 
elimination. If the food causes symptoms, then the patient will generally be aware of either 
nasal or non-nasal symptoms after the food challenge. Those who note symptoms on 
reintroduction of the food are instructed to eliminate the food from their diet for 
approximately 3 months, after which time the food may be reintroduced into their diet, 
although the food should not be eaten on a daily basis (Ozdemir et al., 2009). 
Our immune evaluation for patients with RCRS is displayed in Table 1.All patients should 
have complete blood cell count with differential, measurement of serum IgG, IgA, IgM, IgE 
and IgG subclasses as well as allergy skin test or radioallergosorbent test. If serum 
immunoglobulin levels are normal, functional antibody responses should be evaluated by 
determining specific antibody response to an unconjugated pneumococcal polysaccharide 
vaccine. 
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Complete blood cell count with differential 
Quantitative immunoglobulins: IgA, IgE, IgM, IgG and IgG subclasses 
Allergy Test. 
Pneumococcal antibody titers 
Table 1. Immune work up in refractory chronic sinusitis 
In addition to twice daily nasal irrigations and long term nasal steroid all RCRS patients 
with immunodeficiency need to be on prophylactic oral antibiotics. Our protocol is to use 
two different antibiotics rotating every two weeks and so any emerging resistant clones will 
wipe out with the other antibiotic. For many reasons, Bactrim and Doxycycline are our first 
option: They are old, cheap, safe antibiotics and prescribed twice daily. Additionally these 
two antibiotics have a potent anti-inflammatory effect. Cephalexin, Amoxcillin and 
Clarithromycin are alternative options for those patients who are allergic or can’t tolerate 
Bactrim and Doxycycline. The duration of prophylactic antibiotics use is flexible and 
depends mainly on patient’s symptoms duration and clinical response. Antibiotics can be 
used all through the year or given in symptomatic season. Acute exacerbation is treated 
according to endoscopic guided culture. Patients who failed to improve on antibiotics can 
benefit from intravenous or subcutaneous immunoglobulin replacement. The recommended 
stander dose is 400-600 mg/kg given every four weeks for 1-2 years. (Shearer et al 1996). 
Cessation of treatment is schedule during summer months to avoid allergy season and to 
avoid the high incidence of infections during winter. 
3.2 Biofilm & RCRS 
Biofilms are a complex organized community of germs that adhere to the mucosal surface 
and surrounded by a self-produced extensive extracellular polymeric substance called 
(glycocalyx) which composed primarily of polysaccharides. The glycocalyx is a mixture of 
bacterial colonies of different phenotypes with various physiochemical properties. It serves 
as protection for its bacterial inhabitants while also modulating the microenvironment of the 
colonies through its numerous water channels. Biofilms intermittently release free floating 
bacteria (planktonic ) that can provide a constant nidus of infection. 
Biofilm’s life cycle and interactions with the environment can be divided into three stages: 
attachment, growth, and detachment. During the attachment phase,the substratum has to be 
adequate for the reversible adsorption and ultimately the irreversible attachment of bacteria 
to the surface. During the growth phase, as thecells divide and colonize the surface, a 
polysaccharide matrix is formed, and the biofilm begins to display athree-dimensional 
structure. During this phase water channels are formed. Once biofilms reach maturity, 
bacteria slough off and embolize to other areaswhere the process may begin again 
(Sanclement et al.,2005).  
Bacterial biofilms have two microbiological characteristic: first, they are difficult to detect 
and culture using routine conventional methods and second, they are 10-1000 time resistant 
to current antimicrobial therapy when compared with genetically identical planktonic 
bacteria (Kilty & Desrosiers, 2009).  
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Antibiotics resistance is most likely related to biofilm slow growth and metabolic rate as 
well as sharing of multiple resistance genes within the members of the biofilm community. 
Antibiotic treatment will kill bacteria in the periphery where the cells are metabolically 
active, but doesn’t reach the bacteria in the deeper layers of the biofilm. Thus, the biofilm 
serves as a bacterial reservoir that sheds planktonic forms causing systemic illness, 
especially when released intothe circulation. In these circumstances, antibiotic treatment will 
eliminate the circulating bacteria but not the biofilm, leading to recurring acute 
exacerbations (Post et al., 2007).  
Biofilm infection theory may offer an explanation of the high rate of negative sinus cavities 
in CRS and why antibiotic treatment is unable to resolve CRS with bacteria that are sensitive 
to antibiotics.In 2004, Cryer and his colleagues were first to demonstrate the presence of 
biofilms in the biopsied mucosa from a number of symptomatic CRS patients who had prior 
appropriate medical and surgical management (Cryer et al.,2004) .One year later Ramadan 
et al identified biofilms on the mucosa of five patients at the time of ESS.(Ramadan,2006).  
Further studies found significant differences in the rate of biofilms formation between control, 
CRS and refractory sinusitis (Bendouah et al., 2006; Psaltis et al., 2007; Sanclement et al., 2005).  
Another support to the biofilm theory is that pathogenic bacteria most commonly 
implicated in RCRS have been identified in patients with RCRS to exist in the form of a 
biofilm. In several studies  of  bacteriology in  RCRS performed with conventional culture 
methods, Staphylococcus aureus, Coagulase negative staphylococci and Pseudomonas 
aeruginosa have been identified as the most common bacteria to colonize the paranasal 
sinuses and these same species were  the most common bacteria identified in the biofilms of 
refractory sinusitis patients using different invasive labartory techniques. 
The preoperative presence and type of bacteria biofims in sinus mucosa may correlate with 
continuous postoperative symptoms and mucosal inflammation after ESS. Bendouahet et al 
took 31 isolates from 19 CRS patients who had undergone ESS a year earlier. 71% of isolates 
showed biofilm formation. Among the bacteria recovered, Pseudomonas aeruginosa and 
Staphylococcus aureus biofilm was shown to have a correlation with poor outcome after 
ESS, whereas Coagulase negative staphylococci biofilm did not (Bendouah et al., 2006).  
More recently, Psaltis et al retrospectively studied a group of 40 CRS patients who had 
undergone ESS. Outcome measures revealed that bacterial biofilms were found in 50 
percent of the 40 patients and that the poorer post operation symptoms were correlated with 
the presence of bacterial biofilms. Interestingly biofims formation is independent of many 
common risk factors,(such as allergy, polyps, samter’s triad) cited in the etiology of CRS 
were not found to be of significant in ( Psaltis et al., 2008).  
Staphylococcus aureus, Pseudomonas aeruginosa and Coagulase negative staph. are the 
most frequent biofilm forming bacteria in RCRS, these bacteria are usually resistant to oral 
and intravenous antibiotics at minimum inhibitory concentration (MIC). In a study aimed to 
determine the in vitro activity of moxifloxacin against Staphylococcus aureus in biofilm 
form with samples recovered from patients with at least 1 year post-ESS, the authors found 
moxifloxacin at 1000 times the known MIC was statistically significant in reducing the 
number of viable bacteria (Desrosiers et al., 2007). 
In another work, authors studied the MIC of different antibiotics to eradicate Pseudomonas 
aeruginosa biofilms, they found The minimum biofilm eradication concentration for 
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Pseudomonas biofilms has been shown to be 60-fold greater than the MIC for gentamicin 
and greater than 1000-fold for ceftazidime and piperacillin(Ceri, 1999) 
These date and others encourage rhinologist in the past few years toward treating Biofilms 
in RCRS with different delivery methods of topical antibiotics at concentration above the 
MIC level with minimum systemic side effects, taking advantage of the anatomical and 
physiological changes after ESS where paranasal sinuses become single large cavity 
connected with multiple patent ostiums. 
Antibiotics can deliver into nasal cavity by nasal sprays, irrigations, nebulizers or by direct 
installation using syringe and large gauge needle. Because nasal sprays rely on mucociliary 
clearance to transport the drug, and this is often impaired in RCRS, as well as their small 
surface area deposition many believe this method of delivery is suboptimum(Lim et al, 
2008,Richard et al ,2010). 
Most of clinical research on topical antibiotics for RCRS is limited with small number of 
patients, short follow up, different protocols for treatment and inclusions and exclusions 
criteria, however The conclusion of 2 recent review articles support the use of topical 
antibiotics in RCRS and recommend the need of larger and better designed randomized 
double-blinded placebo-controlled studies (Lim et al, 2008,Richard et al ,2010) 
3.3 Osteitis and neo-osteogenesis in RCRS 
Although CRS begins in the mucosa there are evidences that inflammation can spread and 
involve underlying bony structures leading to persistent of patients’ symptoms following 
aggressive medical and proper surgical treatment.The mucosa and underlying bone are not 
separated units and they wee communicate  with each other. 
Bolger et al studied the histopathology changes after induce sinus infection in 33 New 
Zealand white rabbits with Pseudomonas aeruginosa.  Histologic  analysis of the bone 4, 14, 
21, and 28 days after bacterial infection showed stromal changes of bone  resorption, 
reactive osteoblasts, and appositional or intra-membranous new bone formation as early as 
4 days after bacterial inoculation. Bacteria were present in the sinus lumen, surface of sinus 
mucosa, mucosal crypts, mucosal abscesses, and ulcers but not in the bone itself. They 
conclude that although bacteria were limited to the mucosa, the infection induced 
histopathological changes at the submucosa and bone level (Bolger et al., 1997). Using the 
same model and pathogen, Perloff and colleagues confirmed these bony changes to be 
identical to chronic osteomyelitis, interestingly, in all studied specimens some bony changes 
were found at the non-infected side . They suggested that inflammation may travel along 
bone to adjacent sinuses without intervening mucosal disease. Properly inflammatory or 
infectious agents entered the underlying bone, through Haversian canals, and subsequently 
activated the remodeling process in sites distant or adjacent to the original inoculation site 
(Perloff et al.,2000).  
In another study, 14 rabbits were induced by Staphylococcus aureus, chronic osteomyelitis 
in the non-infected side was found in (43%) (Khalid et al., 2002).  
Bony changes had been also reported in studies on patients with CRS.Kennedy et al noted 
marked activity with features of increased fibrosis, remodeling, and woven bone in ethmoid 
labyrinth. Ethmoid septations were found to have evidence of marked acceleration in bone 
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physiology with histologic findings including presence of inflammatory cells, fibrosis, and 
new bone formation. They also reported inflammation in the bone even when the overlying 
mucosa was intact (Kennedy, 1998).  
Giacchiet al. compared bone from ethmoid septa of 20 patients with CRS and control 
group.Those with CRS typically showed periosteal thickening and resorption or 
remodeling. They also found a trend toward more advanced histologic bone stage 
associated with higher CT score indicating that mucosal and bone pathological changes 
occurred simultaneously (Giacchi et al.,2001).  
In a recent study from Netherland , the authors used CT scan to report the incidence of 
osteitis in 102 CRS patients and in an age- and gender matched control group of 68 non-CRS 
patients. Forty per cent of the CRS group and none of the control group had evidence of 
clinically significant osteitis. In the CRS group the severity of osteitis was correlated with 
Lund–Mackay score (P < 0.001), duration of symptoms (P < 0.01) and previous surgery (P < 
0.001). The association between osteitis and number of previous surgery remained strong 
even after adjusting for the disease duration. There was no association between osteitis and 
age, gender, smoking, co-existing asthma, allergy or Sumter’s triad (Georgalas et al. 2010) 
Osteitis and neo-osteogenesis may also affect the success rate after sinus surgery. Kim et al 
studied the correlation between pre-operative bony changes detected in CT scan and 
postoperative endoscopic signs of healed sinus cavities in 81 patients. Patients with no 
radiological signs of bony changes showed better healing mucosa compare to those with 
bony changes (Kim et al., 2006).  
Pathological changes described by human histological studies included: the presence of new 
bone formation, fibrosis, inflammatory cells, periosteal thickening and a varying degree of 
increased osteoblastic– osteoclastic activity, as shown by the disruption of organised 
lamellar bone and formation of immature woven bone, these are best to fit under the terms 
ostitis and neo-osteogesis. Localized or generalized thickened, irregular, heterogeneous 
lining of the sinus walls, is the radiological sign observed in CT scan, as illustrated in Figure 
2 (Georgalas et al., 2010). 
Osteitis and neo-osteogenesisin CRS are probably secondary to inflammatory process rather 
than direct bacterial invasion. In all animals and human studies, bacteria were not detected 
in the inflamed bone except in Tovi’s study where actinomycosis was found in one patient 
(Tovi et al., 1992).  
Cytokines produced by inflammatory cells such as osteoclast activating factor, interleukins, 
and tumor necrosis factor as well as prostaglandins such as prostaglandin 2 are known 
stimulators of bone resorption. These could be important mediators in inflammatory bone 
resorption and bone loss such as in periodontal disease and arthritis(9). Prostaglandin E is 
also shown to cause hyperostosis with periosteal osteoblast proliferation, thickened 
periosteum, and neocortex formation (Kocak et al., 2002; Faye-Petersen et al., 1996).  
Mechanical pressure resulting from increased intrasinus pressure caused by inflammation 
and ostiomeatal unit obstruction may stimulate bone remodeling. This could explain the 
trend toward more advanced bone stage associated with higher CT stage of mucosal disease 
observed by Giacchi et al . 
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Fig. 2. Coronal and axial CT for patient with RCRS showed osteitis in the maxillary wall. 
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Another possible explanation is bacterial Biofilms may act as a ‘depot’ for low grade 
bacterial production and be responsible for the release of soluble bacterial virulence factors 
that generate local bony changes. The authors of most studies on biofilms and sinusitis 
didn’t specify whether their sinus samples where purely mucosal or with some bony 
fragments, biofilms have been reported to present in infected bone in orthopedic and dental 
literature. Indeed, further studies are needed to determine the exact role of biolms in osteitis 
in RCRS. 
Long therapeutic plan required in management of these patients. Complete removal of crust 
and sequestered bone is essential first step to provide healthy environment for mucosal 
regeneration. Topical combination of antibiotic and steroid may also help. 
3.4 Granulomatous disease and vasculitis in RCRS 
The sinonasal cavity may be the first organ to manifest such a systemic condition. 
Presenting symptoms and signs may be identical to those of other forms of CRS and thus 
these patients may have delay diagnosis. 
The list of granulomatous diseases that can affect the sinonasal tract is extensive Sarcoidosis, 
Wegener’s granulomatosis, Churg– Strauss syndrome, are the most common. Detailed 
history, carful systemic examination and local biopsy of any abnormal looking mucosa may 
be the hint of early identification of these patients. 
Sarcoidosis is an inflammatory multisystem disorder of characterized by noncaseating 
granulomas.  Sinonasal cavity is affected in only 0.7% to 6% of cases. Symptoms that may 
point to sarcoidosis are fatigue, pulmonary symptoms, night sweating, weight loss and 
fever.Physicalsigns include mucosal hypertrophy, purple mucosa with nodules 
(granulomas), and lupus pernio. Diagnosis is based on clinical findings, chest radiography, 
elevated angiotensin-converting enzyme levels, and findings of mucosal biopsy from 
affected mucosa (Matthew, 2008; Ferguson et al., 2009).  
Wegener’s granulomatosis is a rare granulomatous vasculitic disorder, affecting 
primarilymiddle age white people.Sinonasal manifestations are very common and occur in 
up to 89% of patients.Common symptoms include nasal obstruction, bloody rhinorrhea, 
epiphora, and crusting. Patients may present with, septal perforation, mucocele, orbital 
pseudotumor, or saddle-nose deformity. Positive cytoplasmic antineutrophil cytoplasmic 
antibodies and an elevated erythrocyte sedimentation rate suggest the diagnosis. However, 
definitive diagnosis depends on histopathologic analysis of affected mucosa. 
Churg–Strauss syndrome is a multisystem disorder with necrotizing granulomatous 
eosinophilic tissue infiltration. Nasal involvement can occur in up to 75% of patients. Nasal 
polyps and rhinosinusitis are early manifestations of the illness, with subsequent 
development of eosinophilia and systemic involvement. Diagnosis is based on clinical 
findings, positive perinuclearantineutrophil cytoplasmic antibodies, and biopsy. 
Treatment of nasal granulomatous diseases most commonly includes aggressive sinus 
debridement to remove crust formation, saline rinses and topical, systemic, intralesional 
steroids and immunosuppressive medications, surgery is reserved for complicated cases. 
Early consultation with rheumatology and immunology teams is essential for proper 
management plan(Ryan 2008, Ferguson and Otto 2009). 
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3.5 Gastroesophageal reflux disease 
Gastroesophageal reflux disease (GERD) has been implicated as a contributing factor in 
many air way disease processes like: dysphonia, benign vocal cord lesions, vocal 
laryngospasm, subglottic stenosis, asthma, CRS, post nasal drip and idiopathic cough. 
Three mechanisms could explain the effect of GERD on sinusitis: direct exposure of the 
nasopharynx and nose to gastric acid causing mucosal inflammation and impaired 
mucociliary clearance, the second possible mechanism is a dysfunction of the autonomous 
nervous system resulting in vagus nerve stimulation, the third possible mechanism relates 
to the direct role of Helicobacter pylori.  
DelGaudio was first to document nasopharyngeal reflux (NPR) in RCRS patients, in 
prospective study using 24 hour pH study with a specially designed probe with sensors 
located in the nasopharynx, 1 cm above the upper esophageal sphincter, and the distal 
esophagus. 
He found significant differences in the number of patients with NPR events (pH less than 5) 
and GERD between patients with RCRS and two control groups, the first consisted of patients 
who had at least one ESS procedure and had no symptoms of CRS or mucosal inflammation 
with a minimum of 1 year postoperative follow up. The second control group consisted of 
subjects with no history of CRS or sinus surgery. Limitation of this paper was that the study 
and control groups were not matched for age and comorbidities. The study group was older 
than the control group by approximately 10 years, and also, the study group patientshave 
more comorbid conditions, especially asthma, comparedwith the control group. This weakness 
may question the accuracy of the results and conclusions (DelGaudio, 2005). 
In prospective study, DiBaise et al  treated 11 RCRS patients with proton pump inhibitor, 
not all patients had frank symptoms of GERD, Individual sinus symptoms (nasal 
congestion, nasal drainage, sinus pressure, facial headache, malaise) and global satisfaction 
were modestly improved in 25-89% and 91%, respectively, at 12 week (DiBaise et al.,2002).  
Flook and Kumar conducted a recent review analysis for the evidence to link acid reflux 
with chronic sinusitis or any nasal symptoms; their conclusion was that the evidence of a 
link is poor with no good randomized controlled trials available. The few adult studies that 
show any link between acid reflux and nasal symptoms are small case-controlled studies 
with moderate levels of potential bias. There is not enough evidence to consider anti-reflux 
therapy for adult refractory CRS and there is no evidence that acid reflux is a significant 
causal factor in CRS (Flook & Kumar, 2011). 
In our practice, we don’t referred asymptomatic patients with RCRS for 24-hour Ph 
monitoring; however we started all RCRS patients on 20mg omeprazole BID for 3 weeks, if 
patient reports improvement in nasal symptoms or endoscopic score we recommend to 
continue on this regimen for 12 weeks.  
4. Conclusions 
A group of CRS patients continue to be symptomatic after appropriate medical and surgical 
therapy. Detailed history, endoscopic examination, laboratory and immunology tests 
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required to look for any reversible underlying pathology. Further clinical studies and in 
vitro research are in great needed to support and validate the current management protocol. 
The current treatment of RCRS is by nasal toilet, debridement, prophylactic antibiotics and 
immunoglobulin as well as topical medications. 
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